Semaglutide vs Tirzepatide vs Retatrutide: Cost Comparison (2026)

    By Trimi Medical Team13 min read

    Cost is often the deciding factor in GLP-1 medication choice. Brand-name medications can cost $1,000-1,500+ per month, but compounded versions offer the same active ingredients at a fraction of the price. Here is a comprehensive cost comparison to help you make an informed decision.

    Medical Disclaimer: This article is for informational purposes only. Prices are approximate and subject to change. Insurance coverage varies by plan. Compounded medications are prepared by licensed pharmacies under FDA oversight.

    Monthly Cost Comparison

    MedicationBrand-NameWith InsuranceCompounded (Trimi)
    Semaglutide$900-1,350/mo$0-300/mo (varies)$99/mo
    Tirzepatide$1,000-1,500/mo$0-500/mo (varies)$125/mo
    RetatrutideNot yet availableN/AContact for pricing

    Cost Per Pound Lost Analysis

    Looking at cost-effectiveness by weight loss achieved (based on a 200 lb starting weight, 12-month treatment):

    MetricSemaglutide (Trimi)Tirzepatide (Trimi)
    Annual cost$1,188$1,500
    Expected weight loss (200 lb patient)24-30 lbs (12-15%)30-44 lbs (15-22%)
    Cost per pound lost$40-50/lb$34-50/lb

    On a cost-per-pound basis, tirzepatide often provides better value because the additional $26/month produces proportionally more weight loss. However, semaglutide at $99/month remains the most accessible entry point.

    Hidden Costs to Consider

    • Lab work: $50-200 per panel, recommended every 3-6 months
    • Supplements: Protein, electrolytes, multivitamin ($30-80/month recommended)
    • Reduced grocery bill: Eating 30-50% less food saves $100-200/month (a hidden offset)
    • Reduced medication costs: Eliminating BP, diabetes, or cholesterol medications saves $50-200+/month

    Insurance vs. Compounded: Pros and Cons

    • Insurance coverage: May be cheaper if covered, but requires prior authorization, can be denied, and is subject to formulary changes
    • Compounded (Trimi): Consistent pricing, no prior authorization, no supply shortages, but not covered by insurance

    Get the Best Value with Trimi

    No insurance hassles, no prior authorization, no surprise costs. Compounded semaglutide is $99/month and compounded tirzepatide is $125/month. Visit our treatment page to start today.

    Frequently Asked Questions

    Why is compounded GLP-1 so much cheaper?

    Brand-name drug pricing reflects R&D costs, marketing expenses, and profit margins of large pharmaceutical companies. Compounding pharmacies produce the same active ingredient without these overhead costs. The result is a medication that costs a fraction of brand-name pricing.

    Is cheaper medication lower quality?

    No. Compounded medications are prepared by licensed pharmacies that must comply with FDA and state pharmacy board regulations. The active ingredient is the same. The difference is in pricing, not quality.

    Can I use HSA/FSA funds for compounded GLP-1?

    Yes. Compounded medications prescribed by a licensed provider for a medical condition are typically HSA/FSA eligible. Check with your plan administrator for confirmation.

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    Related Reading

    How do the side effects of semaglutide, tirzepatide, and retatrutide compare?

    Semaglutide and tirzepatide are FDA-approved and have well-characterized side-effect profiles dominated by transient gastrointestinal symptoms — nausea, diarrhea, vomiting, constipation. Reported nausea rates are roughly 30–45% for semaglutide, 25–40% for tirzepatide. Retatrutide is investigational (a triple receptor agonist targeting GLP-1, GIP, and glucagon) and not yet FDA-approved; phase-2 data show greater weight loss than tirzepatide but also higher rates of GI side effects, consistent with the broader pharmacological intensity. Side effects in all three diminish at each titration step over 2–4 weeks.

    Side-effect class is the same; rates trend with pharmacological intensity.
    Retatrutide is investigational and not yet FDA-approved.
    Slow titration mitigates GI symptoms across the class.

    Key Takeaways

    • Semaglutide, tirzepatide, and retatrutide share the same dominant side-effect class — gastrointestinal symptoms during dose titration.
    • Retatrutide (a triple agonist on GLP-1, GIP, and glucagon receptors) is investigational; not yet FDA-approved.
    • Side-effect rates trend slightly higher with greater pharmacological intensity, paralleling efficacy.
    • All three follow gradual dose escalation to reduce gastrointestinal effects.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: February 21, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    Arrived within 24 hours. Easy to use. Comes with everything. The year is so worth it.

    Outcome: Same-day delivery experience

    Veronica LarimoreFacebook
    It's only been 2 weeks since I've been taking the VialsRx meds from Trimi. The medication showed up pretty quickly (about 4 days after getting approval from Trimi prescriber) and I received 3 vials for my first 3 months on the subscription. For the price and convenience my take is that Trimi and VialsRx is good.

    Outcome: 4-day delivery; 3 vials for first 3 months; price + convenience verdict positive

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Novo Nordisk (2025). Wegovy (semaglutide) prescribing information. U.S. Food and Drug Administration.Read Study
    2. Eli Lilly and Company (2025). Zepbound (tirzepatide) prescribing information. U.S. Food and Drug Administration.Read Study
    3. Frías JP, et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. The New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2107519

    Was this article helpful?

    Keep Reading

    Complete side effect comparison of semaglutide, tirzepatide, and retatrutide. Nausea, GI issues, hair loss, fatigue, and unique side effects of each medication.

    Four-way comparison of the most prescribed weight loss medications in 2026. Compare efficacy, side effects, cost, duration of use, and who each drug is best for.

    Comparing semaglutide, tirzepatide, and retatrutide specifically for women. Weight loss, hormonal effects, fertility, PCOS, menopause, and side effect differences.

    New SURMOUNT-5 data confirms tirzepatide outperforms semaglutide 20.2% vs 13.7% weight loss. A complete 2026 head-to-head on efficacy, side effects, and cost.

    Start your GLP-1 journey — from $99/mo

    Get Started